SCHEMBL2913577

SCHEMBL2913577

C[C@H](CO)NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.37
PDE2A O00408 5/20 0.32
GCGR P47871 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE10A Q9Y233 1/20 0.32
AXL P30530 2/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
ALOX5AP P20292 3/20 0.32
FEN1 P39748 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
MITF O75030 1/20 0.32
KMT2A Q03164 1/20 0.32
EIF4E P06730 1/20 0.32
HDAC4 P56524 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MERTK Q12866 1/20 0.30
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911914 1.00 AHR (0.37) AHRPDE2AGCGRPDE3APDE10A
SCHEMBL2910232 0.91 MAPT (0.34) GSK3AGSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL2911586 0.91 MAPT (0.34) GSK3AGSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL2913352 0.91 ALOX5AP (0.39) AXLGSK3AGSK3BALOX5APFEN1
SCHEMBL2909824 0.91 ALOX5AP (0.39) AXLGSK3AGSK3BALOX5APFEN1
SCHEMBL2911193 0.90 MET (0.35) AXLGSK3AGSK3BALOX5APFEN1
SCHEMBL2904127 0.90 MET (0.35) AXLGSK3AGSK3BALOX5APFEN1
SCHEMBL2906883 0.89 CFTR (0.38) AHRGCGRAXLGSK3AGSK3B
SCHEMBL2911121 0.89 CFTR (0.38) AHRGCGRAXLGSK3AGSK3B
SCHEMBL2911770 0.89 GSK3B (0.34) GSK3AGSK3BSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed